Pyrantel Embonate, Praziquantel

Verify with FDA CVM →

104 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
104
Total Reports
6
Deaths Reported
580.0%
Death Rate

Active Ingredients

Pyrantel Embonate, Praziquantel

Administration Routes

OralUnknownTopical

Species Affected

Cat 91
Unknown 9
Dog 3
Other 1

Most Affected Breeds

Domestic Shorthair 57
Cat (unknown) 12
Unknown 10
Domestic Mediumhair 6
Domestic Longhair 4
Maine Coon 2
Siamese 2
Domestic (unspecified) 2
Oriental 2
Dog (unknown) 2

Most Reported Reactions

Ataxia 27
Vomiting 24
Lethargy (see also Central nervous system depression in Neurological) 11
Behavioural disorder NOS 8
Diarrhoea 7
Other abnormal test result NOS 6
UNPALATABLE 5
Wobbliness 5
Weight gain 4
Death 4
Emesis (multiple) 4
Not eating 4

Outcome Breakdown

Outcome Unknown
37 (38.5%)
Recovered/Normal
31 (32.3%)
Ongoing
22 (22.9%)
Died
4 (4.2%)
Euthanized
2 (2.1%)

Data Summary

Metric Value
Total adverse event reports 104
Reports involving death 6
Case-fatality rate (reported events) 580.0%
Distinct species in reports 4
Distinct breeds in reports 15
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Pyrantel Embonate, Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 104 adverse event reports referencing Pyrantel Embonate, Praziquantel, including 6 reports in which the animal died — a 580.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Pyrantel Embonate, Praziquantel. Reported administration routes include Oral, Unknown, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Pyrantel Embonate, Praziquantel reports are Cat (91 reports), Unknown (9 reports), Dog (3 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (57), Cat (unknown) (12), Unknown (10) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Pyrantel Embonate, Praziquantel are Ataxia (27), Vomiting (24), Lethargy (see also Central nervous system depression in Neurological) (11), Behavioural disorder NOS (8). Of the 96 reports with a coded outcome, Outcome Unknown is the leading category at 38.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Pyrantel Embonate, Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial